Resultado da Busca
Associate Professor of Pediatrics, Harvard Medical School. View Clinician Profile. Phone: 617-355-2079
K23HL085308 (DE FERRANTI, SARAH D) Sep 1, 2007 - May 31, 2012. NIH. Nutritional Treatment of Overweight Adolescents with Cardiovascular Risk Factors. Role: Principal Investigator. T32HL007572 (DE FERRANTI, SARAH D;NEWBURGER, JANE W.;PU, WILLIAM TSWENCHING) Jan 1, 1983 - Jun 30, 2026. NIH. Research Methods in Pediatric Cardiovascular Disease.
22 de mar. de 2019 · de Ferranti et al CV Risk Reduction in High-Risk Pediatric Patients e604 March 26, 2019 Circulation. 2019;139:e603–e634. DOI: 10.1161/CIR.0000000000000618 CIIC AM D IDI on pathophysiology and epidemiology. The overall ap-proach of risk stratification and preferential use of phar-macotherapy to reduce CVD risk in the highest-risk indi-
Sarah De Ferranti, MD is a Pediatric Cardiologist in Boston, MA. Sarah De Ferranti was board certified by the American Board of Pediatrics. Sarah De Ferranti, MD does not participate in Zocdoc to offer online booking at this time.
30 de abr. de 2021 · SES and SVI were similar between patients with MIS-C and coronavirus disease 2019. In multivariable analysis, lowest SES quartile (odds ratio 2.2 [95% confidence interval 1.1–4.4]), highest SVI quartile (odds ratio 2.8 [95% confidence interval 1.5–5.1]), and racial and/or ethnic minority background were associated with MIS-C diagnosis.
Sarah de Ferranti, MD, MPH (617) 355-2079. Website. More. Directions Advertisement. 333 Longwood Ave Boston, MA 02115 Hours ...
1. Prevalence of cardiovascular risk factors in U.S. young adults aged 18 39 years from the National Health and. Nutrition Examination Survey 2005 2014. aBorderline high cholesterol was defined as total cholesterol (fasting or nonfasting [2.2%]) 200 239 mg/dL and high cholesterol was de ned as total.
